Earning Calls - what seems to be a string of net losses with one positive light from Jazz Pharma
- Savient Pharmaceuticals released its first quarter 2012 financial earnings with a net loss of 34.2M ( a big increase in net loss compared to the $13.5M in net loss of the same quarter of last year). The company had $3.5M in total revenues (increased from $1.3M in the same period of 2011). The company currently has Krystexxa (pegloticase) in the market with the net sales of $3.1M in the first quarter.
- Pacira Pharmaceuticals released the results of its first quarter 2012 with a net loss of 11.9M (an increase from 9.7M from the same quarter of last year. The company has its revenues increased from 3.86M of last year to 7.8M this year. The company currently has